These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24717258)

  • 1. The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: a 12-week double-blind, randomized controlled trial.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Wang TY; Yeh TL; Yang YK; Hong JS; Lu RB
    J Clin Psychopharmacol; 2014 Jun; 34(3):337-43. PubMed ID: 24717258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of add-on low-dose dextromethorphan plus valproic acid in bipolar disorder.
    Chen SL; Lee SY; Chang YH; Chen PS; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1753-9. PubMed ID: 25262178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Yeh TL; Yang YK; Lu RB; Hong JS
    J Psychiatr Res; 2013 Oct; 47(10):1343-8. PubMed ID: 23870798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype variant associated with add-on memantine in bipolar II disorder.
    Lee SY; Chen SL; Chang YH; Chen SH; Chu CH; Huang SY; Tzeng NS; Wang CL; Wang LJ; Lee IH; Yeh TL; Yang YK; Hong JS; Lu RB
    Int J Neuropsychopharmacol; 2014 Feb; 17(2):189-97. PubMed ID: 24103632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Add-On Memantine Treatment for Bipolar II Disorder Comorbid with Alcohol Dependence: A 12-Week Follow-Up Study.
    Lee SY; Wang TY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB
    Alcohol Clin Exp Res; 2018 Jun; 42(6):1044-1050. PubMed ID: 29656414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DRD2/ANKK1 gene is associated with response to add-on dextromethorphan treatment in bipolar disorder.
    Lee SY; Chen SL; Chang YH; Chen SH; Chu CH; Huang SY; Tzeng NS; Wang CL; Lee IH; Yeh TL; Yang YK; Lu RB
    J Affect Disord; 2012 May; 138(3):295-300. PubMed ID: 22326841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial.
    Anand A; Gunn AD; Barkay G; Karne HS; Nurnberger JI; Mathew SJ; Ghosh S
    Bipolar Disord; 2012 Feb; 14(1):64-70. PubMed ID: 22329473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memantine add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized, double-blind, placebo-controlled study.
    Rezaei F; Mohammad-Karimi M; Seddighi S; Modabbernia A; Ashrafi M; Salehi B; Hammidi S; Motasami H; Hajiaghaee R; Tabrizi M; Akhondzadeh S
    J Clin Psychopharmacol; 2013 Jun; 33(3):336-42. PubMed ID: 23609382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memantine efficacy and safety in patients with acute mania associated with bipolar I disorder: a pilot evaluation.
    Keck PE; Hsu HA; Papadakis K; Russo J
    Clin Neuropharmacol; 2009; 32(4):199-204. PubMed ID: 19620854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing clinical responses and the biomarkers of BDNF and cytokines between subthreshold bipolar disorder and bipolar II disorder.
    Wang TY; Lee SY; Chen SL; Chang YH; Wang LJ; Chen PS; Chen SH; Chu CH; Huang SY; Tzeng NS; Li CL; Chung YL; Hsieh TH; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB
    Sci Rep; 2016 Jun; 6():27431. PubMed ID: 27270858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The COMT Val158Met Polymorphism Is Associated With Response to Add-on Dextromethorphan Treatment in Bipolar Disorder.
    Lee SY; Chen SL; Wang TY; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Chen KC; Yang YK; Lu RB
    J Clin Psychopharmacol; 2017 Feb; 37(1):94-98. PubMed ID: 27930497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
    Sachs GS; Vanderburg DG; Karayal ON; Kolluri S; Bachinsky M; Cavus I
    J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N; Mullen J; Paulsson B; Vågerö M
    J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania.
    Eden Evins A; Demopulos C; Nierenberg A; Culhane MA; Eisner L; Sachs G
    Bipolar Disord; 2006 Feb; 8(1):75-80. PubMed ID: 16411983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation's Association with Metabolic Profiles before and after a Twelve-Week Clinical Trial in Drug-Naïve Patients with Bipolar II Disorder.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Wang TY; Yeh TL; Yang YK; Hong JS; Lu RB
    PLoS One; 2013; 8(6):e66847. PubMed ID: 23826157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled study of memantine in the treatment of major depression.
    Zarate CA; Singh JB; Quiroz JA; De Jesus G; Denicoff KK; Luckenbaugh DA; Manji HK; Charney DS
    Am J Psychiatry; 2006 Jan; 163(1):153-5. PubMed ID: 16390905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supraphysiologic doses of levothyroxine as adjunctive therapy in bipolar depression: a randomized, double-blind, placebo-controlled study.
    Stamm TJ; Lewitzka U; Sauer C; Pilhatsch M; Smolka MN; Koeberle U; Adli M; Ricken R; Scherk H; Frye MA; Juckel G; Assion HJ; Gitlin M; Whybrow PC; Bauer M
    J Clin Psychiatry; 2014 Feb; 75(2):162-8. PubMed ID: 24345793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
    de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
    J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.